Book ChapterDOI
Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease
Nima Moaven,Nahid Tayebi,Ehud Goldin,Ellen Sidransky +3 more
- pp 69-90
TLDR
A careful evaluation of one specific Mendelian disorder, Gaucher disease, can learn lessons directly applicable to other diseases, both rare and common, that will help to better understand the complexity in interpreting genetic data in multigene disorders.Abstract:
Mendelian disorders are diseases which occur due to a mutation in the DNA sequence of a single gene. However, as we learn more about these inherited diseases, it is clear that there can be a vast spectrum of associated phenotypes. Gaucher disease is an example of a “simple” monogenic disorder with complex features. It results from the deficiency of the recessively inherited enzyme glucocerebrosidase, and is the most common lysosomal storage disorder. One of the chief clinical challenges facing geneticists and medical practitioners is to assess how adequately one can use genotype data to predict phenotypes. The ability to make such predictions is an essential tenet of individualized medicine and has implications for prenatal decision making. By understanding the limitations of genotype-phenotype correlation in monogenic disorders, we can gain insights that will help us to better understand the complexity in interpreting genetic data in multigene disorders. Factors including genetic modifiers, gene-gene interaction, reduced penetrance, imprinting, processed and non-processed pseudogenes, regulatory polymorphisms, epigenetics and the abundant number of private mutations, provide challenges for those seeking to understand genetic contributions to distinct phenotypes. Through a careful evaluation of one specific Mendelian disorder, Gaucher disease, we can learn lessons directly applicable to other diseases, both rare and common.read more
Citations
More filters
Journal ArticleDOI
Mechanisms of tissue and cell-type specificity in heritable traits and diseases
Idan Hekselman,Esti Yeger-Lotem +1 more
TL;DR: The large prevalence of tissue-selective traits and diseases is discussed, common molecular mechanisms underlying their tissue- selective manifestation are described and computational strategies and publicly available resources for elucidating the molecular basis of their genotype–phenotype relationships are presented.
Journal ArticleDOI
Role of duplicate genes in determining the tissue-selectivity of hereditary diseases.
TL;DR: It is shown for the first time at large-scale via quantitative analysis of omics datasets that, preferentially in the disease-manifesting tissues, paralogs are under-expressed relative to causal genes in more than half of the diseases.
Posted ContentDOI
Role of duplicate genes in determining the tissue-selectivity of hereditary diseases
TL;DR: The results suggest that dosage relationships between paralogs affect the phenotypic outcome of germline aberrations, adding par analogs as important modifiers of disease manifestation.
Journal ArticleDOI
Predicting molecular mechanisms of hereditary diseases by using their tissue-selective manifestation.
Eyal Simonovsky,Moran Sharon,Maya Ziv,Omry Mauer,Idan Hekselman,Juman Jubran,Ekaterina Vinogradov,Chanan M Argov,Omer Basha,Lior Kerber,Yuval Yogev,Ayellet V. Segrè,Hae Kyung Im,Ohad S. Birk,Lior Rokach,Esti Yeger-Lotem +15 more
TL;DR: Tissue Risk Assessment of Causality by Expression (TRACE) as mentioned in this paper is a machine learning approach to predict genes that underlie tissue-selective diseases and selectivity-related features.
Posted ContentDOI
A tissue-aware machine learning framework enhances the mechanistic understanding and genetic diagnosis of Mendelian and rare diseases
Eyal Simonovsky,Moran Sharon,Maya Ziv,Omry Mauer,Idan Hekselman,Juman Jubran,Ekaterina Vinogradov,Chanan M Argov,Omer Basha,Lior Kerber,Yuval Yogev,Ayellet V. Segrè,Hae Kyung Im,Ohad S. Birk,Lior Rokach,Esti Yeger-Lotem +15 more
TL;DR: In this paper, an interpretable machine learning (ML) platform was introduced for the diagnosis of tissue-selective heritable diseases, which can be applied in gene-specific, tissue-specific or patient-specific modes.
References
More filters
Journal ArticleDOI
Variant of TREM2 associated with the risk of Alzheimer's disease
Thorlakur Jonsson,Hreinn Stefansson,Stacy Steinberg,Ingileif Jonsdottir,Palmi V. Jonsson,Jon Snaedal,Sigurbjorn Bjornsson,Johanna Huttenlocher,Allan I. Levey,James J. Lah,Dan Rujescu,Harald Hampel,Ina Giegling,Ole A. Andreassen,Knut Engedal,Ingun Ulstein,Srdjan Djurovic,Carla A. Ibrahim-Verbaas,Albert Hofman,M. Arfan Ikram,Cornelia M. van Duijn,Unnur Thorsteinsdottir,Augustine Kong,Kari Stefansson +23 more
TL;DR: These findings strongly implicate variant TREM2 in the pathogenesis of Alzheimer's disease and find that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer’s disease had poorer cognitive function than noncarriers.
Journal ArticleDOI
Prevalence of lysosomal storage disorders.
TL;DR: There was no significant increase in the rate of either clinical diagnoses or prenatal diagnoses of lysosomal storage disorders during the study period, and as a group, they are relatively common and represent an important health problem in Australia.
Journal ArticleDOI
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Ellen Sidransky,Mike A. Nalls,Jan O. Aasly,Judith Aharon-Peretz,Grazia Annesi,Egberto Reis Barbosa,Anat Bar-Shira,Daniela Berg,Jose Bras,Jose Bras,Alexis Brice,Alexis Brice,Chiung-Mei Chen,Lorraine N. Clark,Christel Condroyer,Elvira Valeria De Marco,Alexandra Durr,Alexandra Durr,Michael J. Eblan,Stanley Fahn,Matthew J. Farrer,Hon-Chung Fung,Ziv Gan-Or,Thomas Gasser,Ruth Gershoni-Baruch,Ruth Gershoni-Baruch,Nir Giladi,Nir Giladi,Alida Griffith,Tanya Gurevich,Tanya Gurevich,Cristina Januário,Peter Kropp,Anthony E. Lang,Guey Jen Lee-Chen,Suzanne Lesage,Karen Marder,Ignacio F. Mata,Anat Mirelman,Jun Mitsui,Ikuko Mizuta,Giuseppe Nicoletti,Giuseppe Nicoletti,Catarina R. Oliveira,Ruth Ottman,Avi Orr-Urtreger,Lygia da Veiga Pereira,Aldo Quattrone,Aldo Quattrone,Ekaterina Rogaeva,Arndt Rolfs,Hanna Rosenbaum,Roberto Rozenberg,Ali Samii,Ali Samii,Ali Samii,Ted Samaddar,Claudia Schulte,Manu Sharma,Manu Sharma,Andrew B. Singleton,Andrew B. Singleton,Mariana Spitz,Mariana Spitz,Eng-King Tan,Eng-King Tan,Nahid Tayebi,Tatsushi Toda,André R. Troiano,Shoji Tsuji,Matthias Wittstock,Tyra G. Wolfsberg,Yih-Ru Wu,Cyrus P. Zabetian,Yi Zhao,Shira G. Ziegler +75 more
TL;DR: Data collected demonstrate that there is a strong association between GBA mutations and Parkinson's disease, and those with a GBA mutation presented earlier with the disease, were more likely to have affected relatives, and were morelikely to have atypical clinical manifestations.
Journal ArticleDOI
Genomewide Association Studies and Assessment of the Risk of Disease
TL;DR: The design of genomewide association studies is described and the extent to which the data they provide are useful in predicting the risk of disease is considered.
Journal ArticleDOI
Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease
Norman W. Barton,Roscoe O. Brady,James M. Dambrosia,A. M. Di Bisceglie,Samuel H. Doppelt,Suvimol Hill,Henry J. Mankin,Gary J. Murray,Robert I. Parker,Charles E. Argoff +9 more
TL;DR: Intravenous administration of macrophage-targeted glucocerebrosidase produces objective clinical improvement in patients with type 1 Gaucher's disease.